Peptides DB
Research-centric peptide and protocol reference hub

Vilon (KE) record · updated 17h ago

Inflammation & immuneHealing & recoveryGrade B · human evidenceResearch use only
All 5 studiesJump to the evidenceCompare
What is Vilon (KE) used for?

KE Dipeptide | Thymus Immune Bioregulator

Primarily researched for · Inflammation & immune

Development stage

where Vilon (KE) sits between preclinical work and regulatory approval
  1. 1Cleared
    Preclinical
    Animal / in-vitro work
  2. 2Cleared
    Phase 1
    Safety in humans
  3. 3Cleared
    Phase 2
    Efficacy signal
  4. 4Current
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 1 registered trial. It describes the research record, not a recommendation.

Identity
NameVilon (KE)
Chain length—
Molecular weight275.3 Da
FormulaC11H21N3O5
Structure typeSmall molecule
ClassImmune
Research levelModerate Research
Discovered byCurated master list · 2026

Mass and formula from PubChem CID 7010502. No verified residue count for this compound.

Pharmacology
Mechanism—
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence—
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Aug 9, 2026. How this works →
Research stats
Total studies5
Human / animal / cellular3 / 0 / 1
Highest trial phasePreclinical
Years covered2022–2025
Latest study28d ago
Publication history
20222025
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

5 rowsOpen in the library →
StudyTypeYearSummary depth
Evaluating Seismocardiography as a Non-Exercise Method for Estimating Maximal Oxygen Uptake.
FindingCPET VO2MAX was 37.2 (8.6) mL/min/kg, n=94.
Human2023Full text read0.90
Auditory Spatial Perception as a Function of Recreational Noise Exposure in Gen-Z Adults with Normal Hearing.
FindingNot reported in abstract.
Human2024Full text read0.80
Hyoid bone-based sex discrimination among Egyptians using a multidetector computed tomography: discriminant function analysis, meta-analysis, and artificial intelligence-assisted study.
FindingAccuracies of machine learning models ranged from 0.8667 to 0.933.
Human2025Full text read0.80
Healthy microbiome-moving towards functional interpretation.
FindingNot reported in abstract.
review2025Full text read0.70
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
FindingNot reported in abstract.
In vitro2022Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Vilon (KE) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Vilon (KE) is discussed should be drawn from it.